I carried out my MSc and PhD in Barcelona (Barril Lab), where I worked with different structure-based drug design methods with the aim to improve drug design for non-standard targets. Mainly, I was involved in the development and application of virtual screening approaches using molecular docking and other complementary methods.
After finishing my PhD in 2017, I stayed in the same lab performing different collaborative projects in the field of epigenetics and cancer, with the aim of finding bioactive compounds targeting “undruggable” proteins.
I also carried out two short stays in the labs of Dr Andreas Bender (Cambridge, UK) and Dr Peter Kolb (Marburg, Germany), where I learnt about genomics and other computational methods.
I joined the Baker Institute in January 2019 as a Research Officer in the Systems Genomics lab, under the supervision of professors Mike Inouye and Agus Salim. My research interests are broad and involve mainly the relationship between genetic variants and their effect on protein structures.
I am currently established in Melbourne.